Abstract:Interactions between small molecules and proteins play critical roles in regulating and facilitating diverse biological functions, yet our ability to accurately re-engineer the specificity of these interactions using computational approaches has been limited. One main difficulty, in addition to inaccuracies in energy functions, is the exquisite sensitivity of protein-ligand interactions to subtle conformational changes, coupled with the computational problem of sampling the large conformational search space of degrees of freedom of ligands, amino acid side chains, and the protein backbone. Here, we describe two benchmarks for evaluating the accuracy of computational approaches for re-engineering protein-ligand interactions: (i) prediction of enzyme specificity altering mutations and (ii) prediction of sequence tolerance in ligand binding sites. After finding that current state-of-the-art "fixed backbone" design methods perform poorly on these tests, we develop a new "coupled moves" design method in the program Rosetta that couples changes to protein sequence with alterations in both protein side-chain and protein backbone conformations, and allows for changes in ligand rigid-body and torsion degrees of freedom. We show significantly increased accuracy in both predicting ligand specificity altering mutations and binding site sequences. These methodological improvements should be useful for many applications of protein-ligand design. The approach also provides insights into the role of subtle conformational adjustments that enable functional changes not only in engineering applications but also in natural protein evolution.

De novo design of drug-binding proteins with predictable binding energy and specificity

Robust de novo design of protein binding proteins from target structural information alone

De novo design of high-affinity binders of bioactive helical peptides

De novo design of protein interactions with learned surface fingerprints

De novo design of high-affinity protein binders with AlphaProteo

Design of High Affinity Binders to Convex Protein Target Sites

Recent Progress Using De Novo Design to Study Protein Structure, Design and Binding Interactions

Customizable de novo design strategies for DOCK: Application to HIVgp41 and other therapeutic targets

Computational Design Of Ligand-Binding Proteins

Improving de novo protein binder design with deep learning

Towards Structure-Based Protein Drug Design

Prospective de novo drug design with deep interactome learning

New trends in computational structure prediction of ligand-protein complexes for receptor-based drug design

De Novo Design of Peptide Binders to Conformationally Diverse Targets with Contrastive Language Modeling

Sequence-specific targeting of intrinsically disordered protein regions

Improved protein binder design using ꞵ-pairing targeted RFdiffusion

Steered Molecular Dynamics Simulation in Rational Drug Design

Widely Used and Fast De Novo Drug Design by a Protein Sequence-Based Reinforcement Learning Model

Coupling Protein Side-Chain and Backbone Flexibility Improves the Re-design of Protein-Ligand Specificity

De novo design of cavity-containing proteins with a backbone-centered neural network energy function

Accurate de novo design of high-affinity protein binding macrocycles using deep learning